Treg and Th2 cells are derived from CD4 differentiation induced by tumor microenvironmental signals, such as tumor antigens, cytokines (such as TGF-β), and other soluble molecules [106], and have strong immunosuppressive, antitumor immunity inhibitory function [107,108,109]. The gene discussed is TGFB1; the disease is neoplasm.